High prevalence of papillary thyroid cancer in Korean women with insulin resistance

Head and Neck

Volumn 38, Issue 1, 2016, Pages 66-71

  Bae, Min Jung ^a   Kim, Sang Soo ^b   Kim, Won Jin ^b   Yi, Yang Seon ^c   Jeon, Yun Kyung ^b   Kim, Bo Hyun ^b   Lee, Byung Joo ^b   Lee, Jin Choon ^b   Kim, In Joo ^b   Wang, Soo Geun ^b   Kim, Yong Ki ^a  

^a Kim Yong Ki Internal Medicine Clinic   (South Korea)

^b Pusan National University Hospital   (South Korea)

^c Busan Veterans Hospital   (South Korea)

Author keywords

hyperglycemia; hyperinsulinemia; insulin resistance; papillary thyroid cancer

Indexed keywords

GLUCOSE; INSULIN; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; THYROID CARCINOMA; BLOOD; BODY MASS; CARCINOMA; CASE CONTROL STUDY; EPIDEMIOLOGY; ETHNOLOGY; METABOLISM; PREDICTIVE VALUE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SOUTH KOREA; THYROID NEOPLASMS;

ADULT; BIOMARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CARCINOMA; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; REPUBLIC OF KOREA; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS;

EID: 84955730920     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23848     Document Type: Article

References (34)

1. Kilfoy BA, Zheng T, Holford TR, et al., International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 2009; 20: 525-531.
2. Lubina A, Cohen O, Barchana M, et al., Time trends of incidence rates of thyroid cancer in Israel: what might explain the sharp increase. Thyroid 2006; 16: 1033-1040.
3. Leenhardt L, Grosclaude P, Chérié-Challine L,; Thyroid Cancer Committee. Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 2004; 14: 1056-1060.
4. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ,. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 2004; 159: 1160-1167.
5. Tseng CH,. Diabetes and risk of prostate cancer: a study using the National Health Insurance. Diabetes Care 2011; 34: 616-621.
6. Tseng CH,. Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan. Diabetologia 2011; 54: 2009-2015.
7. Tseng CH,. Diabetes and non-Hodgkin's lymphoma: analyses of prevalence and annual incidence in 2005 using the National Health Insurance database in Taiwan. Ann Oncol 2012; 23: 153-158.
8. Gursoy A,. Rising thyroid cancer incidence in the world might be related to insulin resistance. Med Hypotheses 2010; 74: 35-36.
9. Pappa T, Alevizaki M,. Obesity and thyroid cancer: a clinical update. Thyroid 2014; 24: 190-199.
10. Rezzõnico J, Rezzõnico M, Pusiol E, Pitoia F, Niepomniszcze H,. Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord 2009; 7: 375-380.
11. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al., Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-1214.
12. Lee S, Choi S, Kim HJ, et al., Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci 2006; 21: 695-700.
13. Levy JC, Matthews DR, Hermans MP,. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21: 2191-2192.
14. Meinhold CL, Ron E, Schonfeld SJ, et al., Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. Am J Epidemiol 2010; 171: 242-252.
15. Boelaert K,. The association between serum TSH concentration and thyroid cancer. Endocr Relat Cancer 2009; 16: 1065-1072.
16. Haymart MR, Repplinger DJ, Leverson GE, et al., Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 2008; 93: 809-814.
17. Kim SS, Lee BJ, Lee JC, et al., Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single-center experience. Endocrine 2011; 39: 259-265.
18. Belfiore A, La Rosa GL, La Porta GA, et al., Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 1992; 93: 363-369.
19. Almquist M, Johansen D, Björge T, et al., Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes Control 2011; 22: 743-751.
20. Kim MR, Kim SS, Huh JE, et al., Neck circumference correlates with tumor size and lateral lymph node metastasis in men with small papillary thyroid carcinoma. Korean J Intern Med 2013; 28: 62-71.
21. Grote VA, Becker S, Kaaks R,. Diabetes mellitus type 2-an independent risk factor for cancer? Exp Clin Endocrinol Diabetes 2010; 118: 4-8.
22. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM,. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194-202.
23. Giovannucci E, Harlan DM, Archer MC, et al., Diabetes and cancer: a consensus report. Diabetes Care 2010; 33: 1674-1685.
24. Inoue M, Tsugane S,. Insulin resistance and cancer: epidemiological evidence. Endocr Relat Cancer 2012; 19: F1-F8.
25. Clemmons DR,. Structural and functional analysis of insulin-like growth factors. Br Med Bull 1989; 45: 465-480.
26. Frasca F, Pandini G, Sciacca L, et al., The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem 2008; 114: 23-37.
27. Vella V, Sciacca L, Pandini G, et al., The IGF system in thyroid cancer: new concepts. Mol Pathol 2001; 54: 121-124.
28. Sahin M, Uçan B, Giniş Z, et al., Vitamin D3 levels and insulin resistance in papillary thyroid cancer patients. Med Oncol 2013; 30: 589.
29. Yasar HY, Ertuʇrul O, Ertuʇrul B, Ertuʇrul D, Sahin M,. Insulin resistance in nodular thyroid disease. Endocr Res 2011; 36: 167-174.
30. Rezzõnico J, Rezzõnico M, Pusiol E, Pitoia F, Niepomniszcze H,. Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid 2008; 18: 461-464.
31. Ayturk S, Gursoy A, Kut A, Anil C, Nar A, Tutuncu NB,. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol 2009; 161: 599-605.
32. Rezzõnico J, Rezzõnico M, Pusiol E, Pitoia F, Niepomniszcze H,. Metformin treatment for small benign thyroid nodules in patients with insulin resistance. Metab Syndr Relat Disord 2011; 9: 69-75.
33. Chen G, Xu S, Renko K, Derwahl M,. Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents. J Clin Endocrinol Metab 2012; 97: E510-E520.
34. Tseng CH,. Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes. Ann Med 2013; 45: 539-544.